Results 51 to 60 of about 9,702 (191)
Dynamic scaffolds for neuronal signaling: in silico analysis of the TANC protein family [PDF]
The emergence of genes implicated across multiple comorbid neurologic disorders allows to identify shared underlying molecular pathways. Recently, investigation of patients with diverse neurologic disorders found TANC1 and TANC2 as possible candidate ...
Gasparini, Alessandra +3 more
core +1 more source
Conceptual Modeling of mRNA Decay Provokes New Hypotheses [PDF]
Biologists are required to integrate large amounts of data to construct a working model of the system under investigation. This model is often informal and stored mentally or textually, making it prone to contain undetected inconsistencies, inaccuracies,
Choder, Mordechai +4 more
core +3 more sources
XPO1 Inhibitor Approved for Multiple Myeloma [PDF]
Abstract The FDA granted accelerated approval to selinexor plus low-dose dexamethasone for triple-class refractory multiple myeloma, despite an advisory panel's concerns about the drug's toxicity and the lack of randomized clinical data.
openaire +1 more source
XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
Background Exportin 1 (XPO1) is a nuclear export protein that facilitates the transportation of various substances. XPO1 promotes tumor development as a poor prognostic factor in a variety of tumors and is a therapeutic target for screening inhibitors ...
Ying Han +7 more
doaj +1 more source
XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. [PDF]
Treatment options for high grade urothelial cancers are limited and have remained largely unchanged for several decades. Selinexor (KPT-330), a first in class small molecule that inhibits the nuclear export protein XPO1, has shown efficacy as a single ...
Baek, Han Bit +14 more
core +1 more source
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia [PDF]
This study was supported by the Instituto de Salud Carlos III (ISCIII) PMP15/00007; Ministerio de Economía y Competitividad (MINECO) SAF2015-64885-R; Generalitat de Catalunya AGAUR 2014-SGR-795; and Gilead Spain (GLD15/00288).
Clot, G. +4 more
core +2 more sources
ABSTRACT Patients with relapsed/refractory multiple myeloma (RRMM) who are penta‐drug refractory, defined as resistant to two proteasome inhibitors, two immunomodulatory agents, and an anti‐CD38 monoclonal antibody, face a dismal prognosis, particularly after exposure to T‐cell–redirecting therapies.
Maximilian Al‐Bazaz +22 more
wiley +1 more source
Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen [PDF]
International audienceBACKGROUND: The genus Flavivirus encompasses more than 50 distinct species of arthropod-borne viruses, including several major human pathogens, such as West Nile virus, yellow fever virus, Japanese encephalitis virus and the four ...
Marc Le Breton +9 more
core +2 more sources
The past, present, and future of CRM1/XPO1 inhibitors
Therapies targeted at inhibiting nucleo-cytoplasmic transport have found broad applications in the field of oncology. Chromosome region maintenance 1 (CRM1), better known as exportin 1 (XPO1), is the protein transporter responsible for the nucleo-cytoplasmic shuttling of most of the tumor suppressor proteins (TSP) and growth regulatory factors. XPO1 is
Amy Y, Wang, Hongtao, Liu
openaire +2 more sources
Tetrazine Ligation in Living Systems: Beyond Fast Kinetics to Effective Bioorthogonality
Rapid reaction kinetics (k2) alone do not ensure successful tetrazine ligation in living systems. This review introduces ‘effective orthogonality’—focusing on chemical survival, availability, and encounter—as a practical framework. We highlight how bottlenecks shift from cellular sinks to in vivo delivery limits, offering design strategies for reliable
Junhyeong Yim +3 more
wiley +1 more source

